Medicaid expands vaccine access for low-income kids, guarantees provider pay

What it does

This bill expands Medicaid and CHIP coverage of childhood vaccines and vaccine administration services, requires states to pay providers at Medicare rates for vaccine administration through 2028, and increases federal Medicaid matching funds by 1 percentage point for states that conduct vaccination outreach. It also mandates CDC reporting on vaccination rates and tribal data access for epidemiology centers.

Why we flagged it

The bill's core mechanism is expanding Medicaid/CHIP vaccine coverage and guaranteeing provider reimbursement at Medicare rates to improve childhood immunization access. This is straightforward public health policy, not a hidden carve-out or subsidy.

What the text implies

• The 1 percentage point FMAP increase (2027–2028) is time-limited and conditional on state vaccination outreach; states failing to meet messaging requirements lose the increase, creating potential equity gaps if some states cannot meet compliance standards.
• Vaccine administration payment floors (100% of Medicare Part B rates) apply only through December 31, 2028; after that date, reimbursement reverts to state-determined rates, potentially creating a cliff that reduces provider participation.
• The bill expands the definition of 'federally vaccine-eligible child' to include CHIP-enrolled children, but does not explicitly address whether this triggers additional federal vaccine supply obligations or only payment obligations.
• CDC reporting requirements on vaccination rates by demographic factors may expose disparities in vaccine uptake, potentially creating political pressure on states or providers but without corresponding enforcement mechanisms.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill removes barriers to vaccine access for low-income children by expanding eligibility, guaranteeing provider payment at Medicare rates, and incentivizing state vaccination outreach. These measures directly reduce out-of-pocket costs and improve access to preventive care for vulnerable populations.

Who stands to gain

• vaccine manufacturers (increased demand from expanded coverage)
• healthcare providers administering vaccines (guaranteed Medicare-rate reimbursement)
• state Medicaid programs (1 percentage point FMAP increase reduces state match requirement)

Named in the bill

Centers for Disease Control and Prevention (CDC), Medicaid, CHIP (Children's Health Insurance Program), Vaccines for Children program, Medicare Part B, tribal epidemiology centers, state health departments, Comptroller General

Where it stands

13 cosponsors: 10 Democrats, 3 Republicans.

• Apr 21, 2026 — Introduced · Congress.gov: “Introduced in House”
• Apr 21, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $1,048,023 in lobbying spend. A filing names 50 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Kim Schrier, the sponsor, reported $984,999 in PAC receipts in the 2026 cycle.

• American Academy of Family Physicians — $1,048,023 on 1 filing

Lobbying Disclosure Act filings through Jul 15, 2026. A filing shows who paid to lobby on a bill it names, not what changed.